Impaired glucose tolerance in first-episode drug-na\xefve patients w.pdf (4.14 MB)
Download file

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia.

Download (4.14 MB)
journal contribution
posted on 21.01.2022, 09:03 authored by Leona M Spelman, Patricia I Walsh, Neda Sharifi, Patrick B. Collins, Jogin H Thakore
AIMS: To determine whether there is an association between Type 2 diabetes mellitus and schizophrenia, independent of medication. METHODS: In this cross-sectional study we performed an oral glucose tolerance test on 38 non-obese white Caucasians who fulfilled the criteria for first-episode drug-naïve schizophrenia, 38 control subjects (matched for age, gender, smoking status, alcohol intake and ethnicity) and 44 first-degree relatives of the patients. RESULTS: The frequency of impaired glucose tolerance (IGT), defined by World Health Organization criteria, was 10.5% (n = 4) in patients with schizophrenia, 18.2% (n = 8) in unaffected relatives and 0.0% in healthy control subjects (chi(2) = 4.22, d.f. = 2, P < 0.05). CONCLUSIONS: The high point prevalence of IGT in never-treated patients and relatives supports either shared environmental or genetic predisposition to IGT. Both patients and their relatives present an ideal cost-effective opportunity to screen for Type 2 diabetes mellitus, as they are both easily identifiable.



The definitive version is available at

Published Citation

Spelman LM, Walsh PI, Sharifi N, Collins PB, Thakore JH. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabetic Medicine 2007;24(5):481-5.

Publication Date


PubMed ID



  • School of Pharmacy and Biomolecular Sciences